imatinib mesylate has been researched along with Atrial Fibrillation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariano, C; De Vecchis, R | 1 |
| Blank, SD; Butrynski, JE; Corless, CL; Dressel, DM; Ebrahim, KS; Heinrich, MC; Hornick, JL; Long, KB | 1 |
| Barbosa, MM; Bittencourt, HN; Clementino, NC; Marcolino, MS; Nunes, Mdo C; Ribeiro, AL; Xavier, VF | 1 |
3 other study(ies) available for imatinib mesylate and Atrial Fibrillation
| Article | Year |
|---|---|
Network meta-analysis: a new analysis tool of the experimental evidence.
Topics: Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Dabigatran; Dasatinib; Data Interpretation, Statistical; Humans; Imatinib Mesylate; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Network Meta-Analysis; Pyrimidines; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Warfarin | 2019 |
Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.
Topics: Anoctamin-1; Antineoplastic Agents; Atrial Fibrillation; Benzamides; Chloride Channels; Depression; Gastrointestinal Stromal Tumors; Humans; Hypercholesterolemia; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines | 2010 |
An evaluation of the cardiotoxicity of imatinib mesylate.
Topics: Aged; Antineoplastic Agents; Atrial Fibrillation; Atrial Function, Left; Atrial Function, Right; Benzamides; Blood Pressure; Cardiotoxins; Electrocardiography; Heart Rate; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myeloproliferative Disorders; Piperazines; Pyrimidines | 2008 |